(Q34547180)

2 August 2017

1 reference

title

NKT cells - conductors of tumor immunity? (English)

1 reference

2 August 2017

Dale I Godfrey

0 references

Mark J Smyth

0 references

Hideo Yagita

1 reference

2 August 2017

Nadine Y Crowe

1 reference

2 August 2017

Yoshihiro Hayakawa

series ordinal

1 reference

2 August 2017

Kazuyoshi Takeda

series ordinal

1 reference

2 August 2017

publication date

1 April 2002

1 reference

Current Opinion in Immunology

2 August 2017

published in

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

165-171

1 reference

NKT cells: facts, functions and fallacies.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Mouse CD1-specific NK1 T cells: development, specificity, and function

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

NKT cells and tumor immunity—a double-edged sword

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Inhibition of tumor metastasis by adoptive transfer of IL-12-activated Valpha14 NKT cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Interleukin-12 induces cytotoxic NK1+ alpha beta T cells in the lungs of euthymic and athymic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Potentiation of antitumor effect of NKT cell ligand, alpha-galactosylceramide by combination with IL-12 on lung metastasis of malignant melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Requirement for IFN-gamma in IL-12 production induced by collaboration between v(alpha)14(+) NKT cells and antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Sequential production of interferon-gamma by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of alpha -galactosylceramide

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Differential tumor surveillance by natural killer (NK) and NKT cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Immune suppression and skin cancer development: regulation by NKT cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Immune rejection of a large sarcoma following cyclophosphamide and IL-12 treatment requires both NK and NK T cells and is associated with the induction of a novel NK T cell population

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

MIP-2 recruits NKT cells to the spleen during tolerance induction

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900316-3

7 January 2021

10.1016/S0952-7915(02)00316-3

Identifiers

DOI

1 reference

2 August 2017

1 reference